Author

admin

Browsing

The Senate confirmed President Donald Trump’s nominee Emil Bove as a federal judge Tuesday, handing a controversial leader at the Department of Justice a lifetime role on a powerful appellate court.

Bove was narrowly confirmed to the U.S. Court of Appeals for the 3rd Circuit in a 50-49vote with no support from Democrats. His confirmation followed a contentious weeks-long vetting process that included three whistleblower complaints and impassioned outside figures voicing both support and opposition to his nomination.

Senate Judiciary Committee Chairman Chuck Grassley, R-Iowa, said from the Senate floor before the vote that he supported Bove and believed the nominee had been the target of ‘unfair accusations and abuse.’

‘He has a strong legal background and has served his country honorably. I believe he will be a diligent, capable, and fair jurist,’ Grassley said. 

Bove’s ascension to the appellate court marks a peak in his legal career.

He started out as a high-achieving student, college athlete and Georgetown University law school graduate. He went on to clerk for two federal judges and worked for about a decade as a federal prosecutor in the Southern District of New York, leading high-profile terrorism and drug trafficking cases through 2019.

Alongside Todd Blanche, now a deputy attorney general, Bove led Trump’s personal defense team during the president’s criminal prosecutions. Blanche told Fox News Digital in an interview last month that Bove was a ‘brilliant lawyer’ who authored the vast majority of their legal briefs for Trump’s cases. In a letter to the Senate, attorney Gene Schaerr called Bove’s brief writing ‘superb.’

Bove will leave behind his job as principal associate deputy attorney general at the DOJ. Attorney General Pam Bondi congratulated him in a statement.

‘This is a GREAT day for our country,’ Bondi wrote on X. ‘I cannot thank Emil enough for his tireless work and support at @TheJusticeDept. He will be missed — and he will be an outstanding judge.’

Two Republicans, Sens. Lisa Murkowski of Alaska and Susan Collins of Maine, voted against Bove.

Democrats and some who crossed paths with Bove during his time in New York and at DOJ headquarters fiercely opposed his nomination and said he was unqualified.

One whistleblower, Erez Reuveni, had become a successful prosecutor at the DOJ over the last 15 years when he was fired under Bove’s watch. Reuveni said he was party to a meeting in March in which Bove floated defying any court orders that would hinder one of Trump’s most legally questionable deportation plans, a claim Bove denies. Reuveni also said the culture at the DOJ, particularly during the most intense moments of immigration lawsuits, involved misleading federal judges and was like nothing he had experienced during his tenure, which included Trump’s first term.

Two other anonymous whistleblowers emerged at the eleventh hour during the confirmation process and vouched for Reuveni’s claims.

A spokeswoman for Grassley told Fox News Digital the third whistleblower only brought claims to Senate Democrats and did not attempt to engage with Grassley. Grassley’s staff eventually met with the whistleblower’s lawyers after the chairman’s office reached out, the spokeswoman said.

Grassley said his staff interviewed more than a dozen people to vet the initial whistleblower claims and could not find evidence that Bove urged staff to defy the courts.

‘Even if you accept most of the claims as true, there’s no scandal,’ Grassley said. ‘Government lawyers aggressively litigating and interpreting court orders isn’t misconduct—it’s what lawyers do.’

While in New York, Bove also alienated some colleagues. In 2018, a band of defense lawyers said in emails reported by The Associated Press that Bove could not ‘be bothered to treat lesser mortals with respect or empathy.’ Another lawyer who had interactions with Bove in New York told Fox News Digital he was a ‘bully’ who browbeat people. 

A group that opposes Bove’s nomination, Justice Connection, published a letter signed by more than 900 former DOJ employees calling for the Senate to reject Bove’s nomination.

Among their concerns was that Bove led the controversial dismissal of Democratic New York City Mayor Eric Adams’ federal corruption charges. Several DOJ officials resigned in protest over Bove’s orders to toss out the charges. In the letter, the former employees said Bove has been ‘trampling over institutional norms’ and that he lacked impartiality.

Senate Judiciary Committee Democrats, in an unusual move, staged a walkout at a hearing on Bove before a recent vote to advance his nomination. Senate Minority Leader Chuck Schumer, D-N.Y., called him a ‘henchman,’ a description Democrats have widely adopted for him.

‘He’s the extreme of the extreme,’ Schumer told reporters. ‘He’s not a jurist. He’s a Trumpian henchman. That seems to be the qualification for appointees these days.’

Bove defended himself against critics during his confirmation hearing.

‘I am not anybody’s henchman. I’m not an enforcer,’ Bove said. ‘I’m a lawyer from a small town who never expected to be in an arena like this.’

Fox News’ Alex Miller contributed to this report.

This post appeared first on FOX NEWS

From Gaza to Greenland, French President Emmanuel Macron appears to be taking increasingly bolder diplomatic stabs at President Donald Trump’s foreign policy even though such gestures don’t ‘carry weight’ as Trump pointed out last week after the French leader declared his intention to recognize a Palestinian state.

‘French Presidents from Charles de Gaulle onwards have reveled in the idea that they are a natural counterweight to U.S. foreign policy on the international stage,’ Alan Mendoza, executive director of the U.K.-based Henry Jackson Society, told Fox News Digital Monday.

Charles de Gaulle was France’s long-serving leader in the 1950s and 1960s and was famously resistant to U.S. global dominance, withdrawing his country from NATO’s military command structure in a bid to increase its military independence and criticizing U.S. policies in Eastern Europe and Vietnam.

Such contrarian actions, Mendoza said, ‘have in many ways defined the French Fifth Republic, with larger-than-life characters thrusting their views onto the world stage.

‘The difference now is that France matters far less globally than it did 60 years ago,’ he said, adding that a weakening of the European country’s economy and its military might ‘means that where once de Gaulle could roar, now Macron whimpers.’ 

‘What was once a sign of French strength and confidence now therefore looks more like a desperate attempt to escape irrelevance,’ said Mendoza.

In a dramatic announcement last week, Macron said that at the United Nations General Assembly in September France intends to declare its recognition of a Palestinian state, even as Palestinian terror groups continue to battle Israel in the Gaza Strip. 

The statement drew condemnation from Israeli Prime Minister Benjamin Netanyahu, who said such a move ‘rewards terror.’ 

It was also criticized by Secretary of State Marco Rubio, who called the decision ‘reckless’ and ‘a slap in the face to the victims of October 7th.’ He said the U.S. strongly rejected such a plan. 

Trump merely dismissed Macron’s Gaza move, telling reporters at the White House Friday ‘what he says doesn’t matter.’ 

‘He’s a very good guy. I like him, but that statement doesn’t carry weight,’ the president said.

This is not the first time the president has discounted Macron as inconsequential.

Last month, after the French president speculated about Trump’s reasons for leaving the G7 summit in Canada early and returning to Washington, the president wrote on his Truth Social platform, ‘Wrong! He has no idea why I am now on my way to Washington, but it certainly has nothing to do with a Cease Fire. Much bigger than that. Whether purposely or not, Emmanuel always gets it wrong. Stay Tuned!’ 

In the same post, Trump said Macron was ‘publicity seeking.’ 

The disparaging comments came after Macron directly contradicted Trump’s foreign policy by stopping on his way to the summit in the semi-autonomous Arctic territory of Greenland, which Trump has said he wishes to acquire. 

‘Greenland is not to be sold, not to be taken,’ Macron declared in a diplomatic stab at Trump’s foreign policy and seemingly an attempt to rally support from other European countries to stand up to the U.S. 

Asked about Trump’s ambitions for Greenland, Macron, according to Reuters, said, ‘I don’t think that’s what allies do. …  It’s important that Denmark and the Europeans commit themselves to this territory, which has very high strategic stakes and whose territorial integrity must be respected.’

In February, the French president paid his first visit to the White House since Trump’s return to power, and while the meeting appeared to be warm, it also came amid tension over the U.S. approach to the Russia-Ukraine war.

Hours before the meeting, the U.S. voted against a United Nations resolution drafted by Ukraine and the European Union condemning Russia for its invasion.

Tensions between Macron and Trump are not personal, said Mendoza, but they are also not totally ideological. 

They stem from Macron’s ‘desire to be relevant and to stand for something,’ he said. ‘The French are famous contrarians, but they do it for the sake of being contrarian.’

Reuel Marc Gerecht, a resident scholar at the Foundation for Defense of Democracies, the Washington, D.C., think tank, said Macron was no ‘different from most European leaders. … Trump just isn’t their cup of tea.’

‘Most view Trump as a convulsive, hostile force who views America’s historic relationship with Europe as transactional,’ he said.  

‘Macron, like most French leaders, defines himself in part against the U.S.,’ Gerecht added, explaining that, traditionally, France and America ‘had a ‘mission civilisatrice’ or a competitive enlightenment mission.’ 

‘The American way has been enormously appealing in Europe since World War II, but it has come in part at the expense of the French, who have culturally lost a lot of ground to the Anglophones, especially the Americans,’ he said. ‘Consequently, many Frenchmen have a love-hate relationship with the U.S.’   

On Macron, Gerecht added, ‘He is part of the French elite. They are a bright lot who punch way above their weight, but, educationally, temperamentally, they are nearly the opposite of Trump.’ 

This post appeared first on FOX NEWS

Sranan Gold (CSE:SRAN,FSE:P84) is a junior exploration company focused on Suriname, a South American country that produces over 600,000 ounces of gold annually. The company’s flagship project is located in the highly prospective Guiana Shield, one of the world’s most underexplored and gold-rich geological regions.

Sranan’s 29,000-hectare Tapanahony gold project sits atop a historic mining belt with strong geochemical and structural markers. Leveraging local knowledge, legacy drill data, and modern exploration tools, the company aims to define its first gold resource along a 4.5 km mineralized corridor.

Backed by the discovery team behind Suriname’s major deposits—Merian, Rosebel, and Saramacca—Sranan is targeting hard-rock gold beneath saprolite zones, with plans to accelerate drilling, grow its land position, and deepen community ties.

Company Highlights

  • District-scale land position: The 29,000-hectare Tapanahony project covers one of Suriname’s oldest and most productive artisanal mining districts, offering untested hard-rock upside within the Guiana Shield, home to numerous multi-million-ounce gold deposits.
  • Immediate drill targets: A 10,000-metre diamond drilling program is set to kick off in 2025 across the 4.5 km Poeketi-Randy trend, targeting high-grade shear zones validated by historic IAMGOLD drilling.
  • World-class discovery pedigree: The technical team has led or co-led discoveries at Merian (7 Moz, Newmont), Rosebel (13.7 Moz, now Zijin) and Saramacca (1.5 Moz).
  • Deep in-country knowledge: Geologists are locally trained at Anton de Kom University and have decades of experience in Suriname’s regolith-dominated terrain.

This Sranan Gold profile is part of a paid investor education campaign.*

Click here to connect with Sranan Gold (CSE:SRAN) to receive an Investor Presentation

This post appeared first on investingnews.com

The uranium market entered Q2 on shaky footing, with spot prices slipping to around US$63.50 per pound (March 13)—the lowest level in 18 months—as utilities hesitated to contract amid ample secondary supply and demand uncertainty.

By early June, however, spot prices rebounded to the US$70–US$71 per pound range, buoyed by geopolitical tailwinds and renewed nuclear policy support in the US.

While the spot market showed typical volatility, long-term contract prices remained stable around US$80 for the first six months of the year, underscoring producer discipline.

Utilities have so far stayed largely on the sidelines, but expectations are mounting for a wave of contracting in the second half.

Uncertainty impacting utility sentiment

Trade tensions and tariff threats from US President Donald Trump have been a catalyst for volatility in the uranium market through the first half of 2025.

Term uranium contracting remains well below replacement levels despite firm prices and growing demand, according to Oceanwall’s Ben Finegold.

“Term prices are sitting around US$80 per pound right now—roughly US$6 to US$7 above spot—but it’s still extremely difficult to get reliable data on actual volumes and pricing,” said Finegold during the Bloor Street Capital Virtual Uranium Conference in June.

By mid-year only 25 million pounds had been contracted, putting the market on track to fall 75 percent short of replacement-rate contracting. That shortfall has been a recurring issue, with contracting volumes lagging for more than a decade.

While 2023 saw the strongest term contracting in years (160 million pounds), about 30 percent of that came from a single deal. In 2024, 110 million pounds were contracted, well above where 2025’s totals are likely to fall.

Uncertainty continues to weigh heavily on term uranium contracting, particularly among U.S. utilities, who remain unsure about the future of US-Russia relations and whether Russian supply will remain accessible.

“There’s a certain naivety among fuel buyers,” said Finegold, referencing a recent conversation with a former buyer who suggested utilities have grown used to a decade-long environment where they could easily dip in and out of the spot or term market.

But that era may be ending.

“I just don’t see a situation where the supply-demand fundamentals get better for utilities,” the source added.

Despite global momentum—31 countries aim to triple or quadruple nuclear capacity by 2050 and the US government has pledged US$75 billion toward domestic reactor builds—contracting volumes remain surprisingly low.

“It’s a pressure cooker,” said Finegold. “At some point something has to give—and when utilities return to the term market, history shows they tend to do so all at once.”

Supply gap to collide with surging demand

From a structural perspective, the market is grappling with a widening supply deficit: global production in 2024 met just 80 percent–90 percent of reactor demand, with the shortfall made up through inventories and spot purchases—a buffer that is fading fast.

Meanwhile, development pipelines are thin, projects suffer regulatory delays, and geopolitical constraints—including Russia sanctions—further limit available supply options. Further compounding the issue are the 69 nuclear reactors that are in the process of being built, in addition to the 440 operational reactors around the globe.

The need for uranium is especially prevalent in the US where 45 million pounds are consumed annually, while the country produces roughly 1 percent of that.

In an effort to remedy this discrepancy, President Trump issued several Executive Orders in early 2025 and targeted energy production in his “big beautiful bill”.

Included within these measures Trump has proposed an increase in nuclear energy targeting 400 gigawatts by 2050.

The uptick would mark a fourfold increase from the country’s current 100 gigawatts of capacity—far exceeding the International Atomic Energy Agency’s projected range of 89 to 142 gigawatts for all of North America.

If realized, this expansion would push U.S. uranium demand from about 50 million pounds of U3O8 equivalent annually to nearly 200 million pounds—an amount that alone would nearly double current global mine output, which UxC estimates at 164 million pounds for 2025.

“The US is signaling a once-in-a-generation commitment to domestic uranium independence and advanced nuclear deployment,” wrote Sprott’s Jacob White, in a June uranium report.

While the scale of future demand will depend on execution challenges such as permitting, grid infrastructure, and financing, analysts say the scenario presents “asymmetrically positive” risk, offering potential upside to long-term uranium demand forecasts.

This thesis was further bolstered when the Trump admin fast tracked permitting for the Anfield Energy’s (TSXV:AEC,OTCQB:ANLDF) Velvet-Wood project in Utah and Laramide Resources’ (TSX:LAM,ASX:LAM,OTCQX:LMRXF) Crownpoint-Churchrock and La Jara Mesa uranium projects in New Mexico.

“For the first time under the current policy framework, a uranium mine, Anfield’s … received US approval in just 14 days,” the Sprott report noted.

“This demonstrates how quickly support for domestic supply can translate into tangible action. The project was permitted under Trump’s emergency energy declaration, reinforcing a shift toward uranium as a strategically vital input.”

Elsewhere uranium supply could face headwinds. Kazakhstan, which accounts for roughly 40 percent of global uranium output, is unlikely to boost production meaningfully.

“I see Kazakhstan as sort of the 800 pound gorilla in the room,” said Finegold.

Kazatomprom, the country’s state-owned uranium company, reduced its 2025 production guidance, by 12 percent–17 percent, due to a critical shortage of sulfuric acid, the chemical essential for its in-situ leach mining process.

Further complicating the outlook, the company’s planned acid production facility isn’t expected online until 2026 or later. Additionally, anticipated increases in Kazakhstan’s mineral extraction tax beginning in 2025 threaten to raise production costs significantly, eroding the company’s historical cost advantage over peers.

Finegold also sees potential issues arising in projected Canadian supply. He noted that the market assumes that developers like NexGen Energy (TSX:NXE,NYSE:NXE), Denison Mines (TSX:DML,NYSEAMERICAN:DNN), Fission Uranium (TSX:FCU), and Paladin Energy (ASX:PDN,OTC:PALAF) will hit timelines and budgets

“And that’s just not how uranium mining works,” he said, pointing to similar issues with North American counterpart Peninsula Energy ASX:PEN,OTC:PENMF).

Peninsula just canceled contracts for 2 million pounds—that demand doesn’t disappear,” he said. “It’ll need to be filled elsewhere, likely via the spot market.”

Uranium-themed equities surge on global nuclear momentum

As highlighted in the Sprott report uranium’s mid-year price ignited a rally in mining equities which posted a 16.22 percent gain by June.

“This sharp equity rebound points to the sector’s leverage to increases in the spot price and catch-up potential, especially as investor sentiment begins to recover,” it read.

Furthermore, the Sprott Physical Uranium Trust’s (TSX:U.U,OTCQX:SRUUF) mid-June US$200 million capital raise bolstered market sentiment and boosted uranium prices and equities.

As John Ciampaglia, CEO of Sprott explained during the virtual uranium event, the move was a strategic play aimed at taking advantage of what the firm viewed as a temporary and unsustainable dip in uranium prices.

He noted investors from Australia led the raise, followed by North American and European interest.

Van Eck’s Uranium and Nuclear Technologies UCITS ETF (LSE:NUCL), also made large gains in 2025, growing its assets under management to over US$500 million in mid-June and then to US$926.6 million by the end of July.

“Nuclear re-entered the public conversation in 2024,” said Sudiyarov, noting the shift followed years of muted sentiment in the wake of the 2011 Fukushima disaster.

While 2022 marked the initial turning point—spurred by Europe’s energy crisis and an urgent search for stable power sources—it wasn’t until last year that nuclear power fully took center stage.

“In 2022 and 2023, the uranium price story led the narrative, but in 2024, nuclear itself became the headline,” he said, pointing to growing political support and corporate endorsement, including power purchase agreements signed by major US tech firms.

The fund also benefited from its lighter exposure to uranium prices compared to peers, allowing it to outperform during a period of spot price softness. “That combination of strong nuclear sentiment and more resilient positioning helped us attract significant inflows.”

Tracking the MarketVector Global Uranium and Nuclear Energy Infrastructure Index, the fund holds roughly 33 companies across the uranium fuel cycle, reactor technologies, services, and utilities.

The ETF is structured around three distinct pillars, according to Sudiyarov.

“The first pillar is uranium miners and companies in the uranium business,” he said, noting this includes traditional miners as well as firms like Yellow Cake that stockpile physical uranium.

The second category focuses on nuclear pure plays, including small modular reactor (SMR) developers like NuScale (NYSE:SMR) and domestic nuclear fuel producers such as Centrus Energy (NYSE:LEU).

The third pillar was developed to broaden exposure beyond competitors’ uranium-heavy strategies.

“We wanted a more even split,” Sudiyarov explained. “So we decided to tap into industrial conglomerates with significant nuclear business units.”

On the investor side, interest in uranium appears to be growing.

“Last year, I had maybe one or two calls about uranium. This year, I’ve had a lot already,” he said, suggesting rising attention from institutional investors.

Growing political acceptance, especially around energy security and defense, has helped reduce the hesitation seen among more conservative investors.

“Once they realize the theme is back in vogue, they feel more comfortable,” he said.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

 

Westport Fuel Systems Inc. (‘Westport’ or the ‘Company’) (TSX:WPRT Nasdaq:WPRT), today announced the successful closing of the previously announced transaction to divest its Light-Duty Segment and outlines its strategic vision for future growth, emphasizing expansion of market share, entering new markets and right sizing its current operations.

 

Today, Westport closed the sale of the Light-Duty Segment to a wholly-owned investment vehicle of Heliaca Investments Coöperatief U.A. (‘Heliaca Investments’), a Netherlands based investment firm supported by Ramphastos Investments Management B.V., a prominent Dutch venture capital and private equity firm (the ‘Transaction’). The Transaction, initially announced on March 31, 2025, includes the sale of Westport Fuel Systems Italia S.r.l., encompassing the Light-Duty OEM, delayed OEM, and independent aftermarket businesses. Total consideration for the assets was a base price of approximately $79.5 million (€67.7 million), subject to certain adjustments, along with potential earnouts of up to a revised estimate of $3.9 million (€3.3 million) based on future performance milestones.

 

‘The successful completion of the disposition of our Light-Duty Segment marks a pivotal step in strengthening our balance sheet,’ said Dan Sceli, Chief Executive Officer of Westport Fuel Systems. ‘More importantly, it allows Westport to sharpen our focus on the larger, higher-growth opportunities ahead, including providing the most economical solutions for heavier duty and high horse power commercial mobility and industrial applications that also deeply decarbonize these challenging segments – where we believe our products and technologies can deliver the greatest value.’

 

  The New Westport  

 

With the successful completion of the Light-Duty Segment divestiture, Westport is taking the necessary steps to execute on a new and focused integrated business strategy. The Company recognizes the evolving macroeconomic environment and is positioning itself to capitalize on renewed market momentum, drive operational excellence, and deliver on key financial objectives.

 

‘The transportation landscape is shifting, and customer demand for cleaner, smarter, and more sustainable solutions continues to accelerate,’ added Sceli. ‘We’re seeing renewed attention on CNG and LNG fuelled platforms and Westport is uniquely positioned to deliver the necessary products and technologies. By leveraging our core strengths in fuel-agnostic, high-pressure fuel systems, we aim to meet growing market demand and provide our customers with reliable solutions that perform – and in many cases are more affordable than the incumbant engines.’

 

During the upcoming Q2 financial results conference call, Westport will be covering additional details about the transaction and Westport’s strategy ahead. We will focus on key priorities, including:

 

  • Cespira: Strategic market expansion and technology leadership in heavy-duty transportation and off road high horse power mobility
  •  

  • High Pressure Controls and Systems: Complementing the energy transition with versatile solutions that support multiple powertrain platforms
  •  

  • Westport Financial Initiatives: Balancing opportunity scale, execution performance, and dynamic market conditions
  •  

Westport’s key focus going forward recognizes both the opportunities and headwinds in overall market conditions. We have initiated a comprehensive internal process to review additional ways to maximize our economic benefit from this recent transaction for our stakeholders. We look forward to providing additional insight and updates when we report Q2 2025 results on Monday, August 11, 2025, after market close.

 

  About Westport Fuel Systems  

 

Westport is a technology and innovation company connecting synergistic technologies to power a cleaner tomorrow. As a leading supplier of affordable, alternative fuel, low-emissions transportation technologies, we design, manufacture, and supply advanced components and systems that enable the transition from traditional fuels to cleaner energy solutions.

 

Our proven technologies support a wide range of clean fuels – including natural gas, renewable natural gas, and hydrogen – empowering OEMs and commercial transportation industries to meet performance demands, regulatory requirements, and climate targets in a cost-effective way. With decades of expertise and a commitment to engineering excellence, Westport is helping our partners achieve sustainability goals – without compromising performance or cost-efficiency – making clean, scalable transport solutions a reality.

 

 Westport Fuel Systems is headquartered in Vancouver, Canada. For more information, visit   www.westport.com   .

 

  Cautionary Note Regarding Forward-Looking Statements  

 

  This press release contains forward-looking statements, including statements regarding the anticipated benefits of the Transaction, including potential earn-out payments, the ability to strengthen our balance sheet, the ability to capitalize on higher-   growth opportunities   ,   and our expectations regarding the future success of our business.   Other forward-looking statements included in the release include those relating to Westport’s future strategic plans, business opportunities and use of the Transaction proceeds. These statements are neither promises nor guarantees but involve known and unknown risks and uncertainties and are based on both the views of management and assumptions that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activities, performance, or achievements expressed in or implied by these forward-looking statements. These risks, uncertainties, and assumptions include those related to governmental policies, regulation and approval, the achievement of the performance criteria required for the earnout described above, purchase price adjustments contained in the Agreement, the demand for our products, as well as other risk factors and assumptions that may affect our actual results, performance, or achievements, as discussed in our most recent Annual Information Form and other filings with securities regulators. Readers should not place undue reliance on any such forward-looking statements, which speak only as of the date they were made. We disclaim any obligation to publicly update or revise such statements to reflect any change in our expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in these forward-looking statements except as required by National Instrument 51-102. The contents of any website referenced in this press release are not incorporated by reference herein   .  

 

  Investor Inquiries:  
Investor Relations
T: +1 604-718-2046
E:   invest@westport.com   

 

   

 

 

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com

Maritime Resources Corp. (TSXV: MAE,OTC:MRTMD) (‘Maritime’ or the ‘Company’) is pleased to announce the full cash repayment of the US$5 million principal amount owed under its non-convertible senior secured notes due on August 14, 2025 (the ‘Notes’), along with accrued and unpaid interest for the month of July 2025. In order to repay the Notes, the Company used the proceeds from its recently completed brokered ‘best efforts’ private placement offering of common shares in the capital of the Company, as announced on July 17, 2025. Payment for the Notes was processed today through Computershare Trust Company of Canada.

Garett Macdonald, Chief Executive Officer of Maritime, commented: ‘We would like to take this opportunity to thank each of the noteholders for their support of the acquisition of the Point Rousse Project which included the Pine Cove Mill in August 2023 through the senior secured note facility. The Company is once again debt-free with the full repayment of the Notes.’

About Maritime Resources Corp.

Maritime (TSXV: MAE,OTC:MRTMD) is a gold exploration and development company focused on advancing the Hammerdown Gold Project in the Baie Verte District of Newfoundland and Labrador, a top tier global mining jurisdiction. Maritime holds a 100% interest directly and subject to option agreements entitling it to earn 100% ownership in the Green Bay Property which includes the former Hammerdown gold mine and the Orion gold project. Maritime controls over 439 km2 of exploration land including the Green Bay, Whisker Valley, Gull Ridge and Point Rousse projects. Mineral processing assets owned by Maritime in the Baie Verte mining district include the Pine Cove mill and the Nugget Pond gold circuit.

On Behalf of the Board:

Maritime Resources Corp.

Garett Macdonald, MBA, P.Eng.
President and CEO
Phone: (416) 365-5321
info@maritimegold.com 
www.maritimeresourcescorp.com

Twitter
Facebook
LinkedIn
YouTube

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/260608

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

As the global push toward electrification accelerates, lithium remains a critical piece of the energy transition.

Continued oversupply remained a persistent headwind for lithium prices through the first half of 2025. Demand for the battery metal jumped 29 percent year-over-year in 2024, fueled by surging electric vehicle sales and rising power needs from sectors like data centers and heavy industry.

Fastmarket’s analysts expect lithium demand to grow 12 percent annually through 2030, supported by structural trends such as renewable energy integration and battery energy storage.

However, a rapid increase in global supply — particularly from China, Australia and South America — has driven prices to multi-year lows, raising concerns about project economics and the sustainability of new production.

Against this backdrop, Canadian lithium stocks are gaining attention as investors look for companies positioned to benefit from long-term demand growth while navigating short-term price pressure.

1. NOA Lithium Brines (TSXV:NOAL)

Year-to-date gain: 58.82 percent
Market cap: C$488.32 million
Share price: C$0.30

NOA is a lithium exploration and development company with three projects in Argentina’s Lithium Triangle region. The company’s flagship Rio Grande project and prospective Arizaro and Salinas Grandes land packages total more than 140,000 hectares.

As NOA works to advance its flagship asset, the company brought on Hatch in April to lead the preliminary economic assessment (PEA).

The PEA will evaluate the project’s economic and development potential with a target production of 20,000 metric tons of lithium carbonate equivalent (LCE) annually, with a scalable plant design that could double capacity to 40,000 metric tons per year.

NOA has also been working to secure a water source in the arid region through a drilling program targeting fresh water. In late June, the company discovered a fresh water source at the project, located near high-grade lithium zones in the project’s northeast area. According to the company, the location means the water source could support future production facilities or evaporation ponds.

The well, drilled to 190 meters in the northern part of the property, is being tested and developed.

Shares of NOA reached a year-to-date high C$0.425 on July 17, 2025.

2. Wealth Minerals (TSXV:WML)

Year-to-date gain: 40 percent
Market cap: C$23.93 million
Share price: C$0.07

Wealth Minerals is focused on the acquisition and development of lithium projects in Chile, including the Yapuckuta project in Chile’s Salar de Atacama, as well as the Kuska Salar and Pabellón projects near the Salar de Ollagüe.

Wealth Minerals’ shares spiked to a year-to-date high of C$0.095 on February 9, 2025, following the company’s acquisition of the Pabellón project.

According to Wealth, Pabellón has been shortlisted by Chile’s Ministry of Mining as a potential site for a Special Lithium Operation Contract based on its geological and environmental suitability. Located in Northern Chile near the Bolivia border, the project spans 7,600 hectares across 26 exploration licenses about 70 kilometers south of the Salar de Ollagüe.

In May, Wealth formed a joint venture with the Quechua Indigenous Community of Ollagüe to advance the Kuska project. The new entity, Kuska Minerals SpA, is 95 percent owned by Wealth and 5 percent by the community, which also holds anti-dilution rights and a seat on the five-member board.

3. Avalon Advanced Materials (TSX:AVL)

Year-to-date gain: 37.5 percent
Market cap: C$38.26 million
Share price: C$0.055

Avalon Advanced Materials is a Canadian mineral development company focusing on integrating the Ontario lithium supply chain. Avalon is developing the Separation Rapids and Snowbank lithium projects near Kenora, Ontario, and the Lilypad lithium-cesium project near Fort Hope, Ontario.

Separation Rapids and Lilypad are part of a 40/60 joint venture between Avalon and SCR Sibelco, with Sibelco serving as the operator.

Avalon started the year with a revised mineral resource estimate for the Separation Rapids project, which boosted resources in the measured and indicated category by 28 percent.

Company shares rose to C$0.07, a year-to-date high, on July 15, the day after Avalon released its results for its fiscal quarter ended May 31.

A week later, Avalon announced an additional C$1.3 million in funding through its C$15 million convertible security agreement with Lind Global Fund II. The drawdown, expected to close within two weeks, will support project development and general corporate needs, according to the company.

4. Frontier Lithium (TSXV:FL)

Year-to-date gain: 20 percent
Market cap: C$125.41 million
Share price: C$0.54

Pre-production mining company Frontier Lithium aims to be a strategic and integrated supplier of premium spodumene concentrates as well as battery-grade lithium salts in North America.

The company’s flagship PAK lithium project, which is a joint venture with Mitsubishi (TSE:8058), holds the “largest land position and resource” in a premium lithium mineral district located in the Great Lakes region of Ontario, Canada. Frontier also owns the Spark deposit, located northwest of the PAK project.

Shares of Frontier Lithium reached a year-to-date high of C$0.79 on March 4. The stock uptick coincided with a government release reporting the federal and provincial governments supported the company’s plans to build a critical minerals refinery in Northern Ontario.

Once complete, the proposed lithium conversion facility will process lithium from the PAK mine project into approximately 20,000 metric tons of lithium salts per year.

In late May, Frontier released a definitive feasibility study for the mine and mill segment of its PAK project. The study outlines a 31 year mine life with average production of 200,000 metric tons of spodumene concentrate. As for the economics, it projects net revenue of C$11 billion, an after-tax NPV of C$932 million and a 17.9 percent internal rate of return.

5. Century Lithium (TSXV:LCE)

Year-to-date gain: 17.31 percent
Market cap: C$51.58 million
Share price: C$0.30

US-focused Century Lithium is currently advancing its Angel Island lithium project in Esmeralda County, Nevada. The company is also engaged in the pilot testing phase at its on-site lithium extraction facility, which will process material from the lithium-bearing claystone deposit.

On May 6, Century Lithium announced the successful completion of testwork on the direct lithium extraction (DLE) process at its demonstration plant.

The results exceeded expectations, showing 91.6 percent lithium recovery and an eluate grade of 575 milligrams per liter (mg/L) from a 328 mg/L lithium concentrate feed. The company says these improvements could significantly reduce capital and operating costs at its Angel Island project.

Shares of Century Lithium registered a year-to-date high of C$0.49 on May 19.

Recently, the company participated in First Phosphate’s (CSE:PHOS,OTCQB:FRSPF) successful production of commercial-grade lithium iron phosphate (LFP) 18650 battery cells.

As noted in the press release, the cells were made using North America-sourced materials, including lithium carbonate from Century’s Angel Island project in Nevada that was processed at its demonstration plant alongside high-purity phosphoric acid and iron from First Phosphate’s Bégin-Lamarche project in Québec, Canada.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

“Whatever is out of favor and hated at the moment, that’s probably what you need to buy,” he said. “Buy it when it’s boring and no one cares, then you get to ride the wave up.”

Barton also broke down his current portfolio, which holds a 30 percent weighting in precious metals—particularly gold—citing concerns over currency policies and the long-term upside for gold and silver.

Watch the interview above for more from Barton on the similarities between poker and resource investing.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic.

Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technologies such as artificial intelligence are playing a role in the landscape as well.

Read on to learn about what’s been driving the share prices of the best-performing Canadian pharma stocks.

1. Cipher Pharmaceuticals (TSX:CPH,OTC:CPHRF)

Year-over-year gain: 48.2 percent
Market cap: C$330.79 million
Share price: C$12.33

Cipher Pharmaceuticals is a specialty pharma company with a diverse portfolio of treatments, including a range of dermatology and acute hospital care products. The company has out-licensed some of its offerings as well. Cipher began trading on the OTCQX Best Market under the symbol CPHRF in early 2024.

In addition to its current portfolio, Cipher has acquired Canadian rights to CF-101, a dermatology treatment for moderate to severe plaque psoriasis is currently expected to undergo Phase III clinical trials. The company is also conducting proof-of-concept studies on DTR-001, a topical treatment for removing tattoos.

In 2024, Cipher announced it had signed a definitive asset purchase agreement with ParaPRO for its US-based Natroba operations and global product rights, and the news caused Cipher’s share price to spike significantly.

During its Q1 results reporting in May 2025, the company announced a US$15 million debt repayment.

2. HLS Therapeutics (TSX:HLS)

Year-over-year gain: 42.03 percent
Market cap: C$154.95 million
Share price: C$4.90

HLS Therapeutics focuses on drugs for cardiovascular and central nervous system problems, often through partnerships. The company specializes in acquiring and commercializing pharmaceuticals that address unmet needs. Key commercial products include Vascepa, Clozaril for treatment-resistant schizophrenia and cholesterol-lowering therapies NEXLETOL and NEXLIZET.

Additionally, the company generates revenue from a diversified portfolio of royalty interests on various products marketed by third parties.

3. Medexus Pharmaceuticals (TSX:MDP,OTC:MEDXF)

Year-over-year gain: 23.25 percent
Market cap: C$92.9 million
Share price: C$2.81

Medexus Pharmaceuticals specializes in bringing drugs to treat rare diseases to North America. The company manages the entire process through its fully integrated operations, from acquiring and developing drugs to marketing and selling them. Some of its key products include treatments for hemophilia B and rheumatoid arthritis, as well as a line of drugs for autoimmune diseases like lupus and allergy treatments.

In November 2024, Medexus Pharmaceuticals announced it had successfully negotiated with the pan-Canadian Pharmaceutical Alliance to make treosulfan, which Medexus commercialized in Canada under the name Trecondyv, available to publicly funded drug programs and patients. Trecondyv is indicated as part of conditioning treatment prior to bone marrow transplants in patients with certain types of blood cancers.

In addition to Canada, Medexus has the exclusive commercialization rights to treosulfan in the US, where it received approval from the US Food and Drug Administration (FDA) in January 2025.

4. Satellos Bioscience (TSXV:MSCL,OTC:MSCLF)

Year-over-year gain: 18 percent
Market cap: C$102.26 million
Share price: C$0.59

Satellos Bioscience is a Canadian pharmaceutical company expanding treatment options for muscle disorders. The company has focused specifically on Duchenne muscular dystrophy, developing therapies to regenerate and repair muscle tissue by targeting the specific biological pathways involved. Its lead candidate SAT-3247 targets a protein called AAK1, which regulates the activity of stem cells that activate and differentiate new muscle fibers.

The company began enrolment for a multiple-ascending-dose arm of the Phase 1 study for SAT-3247 last November after no drug-related adverse events were reported in the single-ascending-dose group.

In May of this year, Satellos announced results from its Phase 1b trial, reporting SAT-3247 has shown positive safety and pharmacokinetic data and encouraging early functional results, clearing the path for a planned Phase 2 trial.

5. NurExone Biologic (TSXV:NRX,OTC:NRXBF)

Year-over-year gain: 1.41 percent
Market cap: C$44.18 million
Share price: C$0.72

NurExone Biologic is the biopharmaceutical company behind ExoTherapy, a drug delivery platform that uses exosomes, which are nano-sized extracellular vesicles, to create treatments for central nervous system disorders, spinal cord injuries and traumatic brain injuries. It is a less invasive alternative to cell transplantation, which requires surgery and carries the risk of rejection.

NurExone’s first nano-drug, ExoPTEN, uses a proprietary sIRNA sequence delivered with the ExoTherapy platform to treat spinal cord injuries. ExoPTEN received orphan drug designation from the US Food and Drug Administration (FDA) in October 2023, meaning it has been recognized as a potential treatment for rare medical conditions. The designation makes it eligible for incentives such as market exclusivity and regulatory assistance aimed at accelerating its development and approval.

The company released preclinical results from animal testing evaluating the efficacy of its nano-drug ExoPTEN in restoring lost vision at the end of 2024. In July 2025, preclinical studies indicated that ExoPTEN could improve walking quality in patients with spinal cord injuries.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Investor Insight

With high-quality, drill-ready assets with world-class discovery potential, Piche Resources is a compelling business case for investors looking to leverage a bull market for uranium and gold.

Overview

Piche Resources (ASX:PR2) is an ASX-listed mineral exploration company focused on uranium and gold exploration in Tier-1 jurisdictions: Western Australia and Argentina. The company holds 100 percent ownership of all of its projects and is supported by a highly experienced board and technical team.

Targeting globally significant discoveries in Tier-1 mineral provinces

Piche’s portfolio includes the advanced-stage Ashburton uranium project in Western Australia and two large-scale exploration projects in Argentina: the Cerro Chacon gold-silver project and the Sierra Cuadrada uranium project. These projects have delivered high-grade exploration results and are drill-ready, positioning the company to unlock significant shareholder value through systematic exploration programmes.

Piche has an internationally recognized board focused on creating long-term shareholder value, and an in-country technical team in Argentina with a proven track record of taking projects from discovery through to development.

Company Highlights

  • Flagship Ashburton uranium project in Western Australia with recent high-grade drilling results over wide intercepts.
  • Sierra Cuadrada uranium project in Argentina showing extensive near-surface mineralisation with assays up to 2.86 percent U₃O₈.
  • Cerro Chacon gold-silver project with high-grade surface results (up to 11.65 g/t gold and 333.7 g/t silver) across a 14 km mineralised corridor.
  • Fully permitted and EIA-approved for drilling at Cerro Chacon (Chacon South and Middle).
  • Large, 100-percent-owned tenement package across all projects (Ashburton: 335 sq km; Cerro Chacon: 414 sq km; Sierra Cuadrada: 1,310 km²).
  • Board of directors includes former leaders of Peninsula Energy, Orano, Rio Tinto Uranium and Barrick Gold.
  • Upcoming drill campaigns planned at Cerro Chacon and Ashburton to test multiple high-priority targets.

Key Projects

Gold: Cerro Chacon, Argentina

Cerro Chacon interpreted geology and tenement holding

Cerro Chacon is a large-scale, early-stage gold-silver exploration project located in the Chubut Province of Argentina. The project is situated within a region known for hosting world-class low-sulphidation epithermal systems, including Cerro Negro and Cerro Vanguardia. With multiple gold-bearing structures confirmed over a 14 km corridor, Cerro Chacon is emerging as a highly promising and underexplored precious metals system with substantial scale and grade potential.

Project Highlights

Location: ~40 km southwest of Paso de Indios, Chubut Province

Tenure: 414 sq km across multiple tenements

Highlights:

  • A 14 km-long mineralised corridor has been delineated across Chacon Grid, La Javiela and Toro Hosco prospects.
  • High-grade geochemical results include:
    • 11.65 g/t gold and 120.3 g/t silver at Toro Hosco
    • 333.7 g/t silver, 9.48 percent lead, and 8.57 percent zinc at La Javiela South
  • Maiden RC drilling programme of 57 holes (7,905 m) scheduled across three main targets:
    • Chacon Grid: 45 holes (5,590 m)
    • La Javiela: 8 holes (1,740 m)
    • Toro Hosco: 4 holes (575 m)
  • EIA approvals for Chacon South and Chacon Middle were received in May 2025, enabling drilling to proceed.
  • Vein systems range from 2 to 6 km in strike length and up to 50 m in width; hosted within structurally controlled low-sulphidation epithermal veins (LSEV).

Uranium: Ashburton Project, Australia

The Ashburton project is Piche’s flagship uranium exploration asset in Australia, situated in the Pilbara region of Western Australia. Located within a historically underexplored but highly prospective unconformity-related uranium district, the project provides the company with strong leverage to the growing global demand for uranium. The project is geologically analogous to world-class Proterozoic uranium systems, with multiple confirmed mineralised zones and a regional corridor of 60 km.

Project Highlights

  • Location: Pilbara region, ~1,150 km north of Perth
  • Tenure: 335 sq km following the recent application for tenement E52/4461 (214 sq km), adding to the existing 122 sq km holdings.
  • Highlights:
    • 2024 RC and diamond drilling confirmed high-grade uranium mineralisation at multiple stratigraphic levels.
    • Best intercepts include:
      • 3.45 m @ 5,129 ppm eU₃O₈ from 137.62 m (ARC006)
      • 10.48 m @ 1,412 ppm eU₃O₈ from 114.30 m (ADD005)
      • 2.42 m @ 2,681 ppm eU₃O₈ from 155.10 m (ADD003).
      • 7.86 m @ 2,266 ppm eU₃O₈ from 105.42 m (ADD006)
    • The company has outlined a 60 km structural corridor hosting multiple uranium occurrences including Angelo A & B, Canyon Creek, Ristretto and Atlantis.
    • Atlantis prospect: historical drilling returned up to 7,400 ppm U₃O₈ over 2.2 m; rock chip samples have returned up to 37 percent U₃O₈.

Uranium: Sierra Cuadrada, Argentina

Sierra Cuadrada is Piche’s primary uranium asset in Argentina, covering a vast area within the San Jorge Basin. This large-scale project has demonstrated strong surface uranium mineralisation with multiple drill-ready prospects. With mineralisation confirmed across extensive zones and supported by historical radiometric and geochemical data, Sierra Cuadrada has the potential to host multiple Tier-1 uranium deposits in a cost-effective, near-surface setting.

Teo 5 and 6 prospect 2024 auger drill programme

Project Highlights:

Location: San Jorge Basin, ~200 km north of Comodoro Rivadavia

Tenure: 1,310 sq km across multiple licences

Highlights:

  • The project area contains broad, flat-lying mineralisation at multiple stratigraphic levels.
  • High-grade uranium assays include:
    • 28,650 ppm U₃O₈ (2.86 percent) from rock chip sampling at Teo 8
    • 24,017 ppm U₃O₈ from channel sampling
    • 2,772 ppm U₃O₈ over 0.5m from auger drill sample
  • Mineralised zones extend over a strike of 60 sq km, with confirmed targets on the majority of tenements.
  • 2024 auger drilling and sampling confirmed uranium continuity across a sandstone and conglomerate sedimentary package with 14 samples exceeding 200 ppm U₃O₈.
  • Rock chip sampling has returned 114 samples >200ppm U₃O₈
  • RC drilling is planned to follow up on anomalies identified in the auger and channel sampling programmes.

Management Team

John (Gus) Simpson – Executive Chairman

John Simpson has over 37 years of experience in mineral exploration, development and mining. Previously the executive chairman and founder of Peninsula Energy Limited (ASX:PEN), a USA uranium producer.

Stephen Mann – Managing Director

Stephen Mann is a geologist with over 40 years of experience in exploration, discovery and development of mining projects, including 20 years in the uranium sector. Formerly the Australian managing director of Orano, the world’s third-largest uranium producer.

Pablo Marcet –Executive Director

Pablo Marcet is a senior geoscientist with 38 years of experience in exploration, discovery and development of mineral deposits. Currently an independent director of lithium producer Arcadium Lithium (NYSE:ALTM) and previously a director of Barrick Gold (NYSE:GOLD) and U3O8 (TSX:UWE).

Clark Beyer – Non-executive Director

Clark Beyer is an internationally recognized nuclear industry executive with over 35 years of experience. Formerly the managing director of Rio Tinto Uranium and currently principal of Global Fuel Solutions, providing strategic consulting to the international uranium and nuclear fuels market.

Stanley Macdonald – Non-executive Director

Stanley Macdonald is a nationally recognized mining entrepreneur, founding director and instrumental in the success of numerous ASX-listed companies, such as Giralia Resources, Northern Star and Redhill Iron. He is currently a director of Zenith Minerals.

This post appeared first on investingnews.com